Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) Net Shares Issued and Repurchased (2022 - 2026)

Genelux (GNLX) posted Net Shares Issued and Repurchased of $288154.0 for Q1 2026, down 84.04% on a QoQ basis from $1.8 million in Q4 2025.

Analysis

Genelux (GNLX) Net Shares Issued and Repurchased (2022 - 2026) Analysis & Trends

Genelux has reported Net Shares Issued and Repurchased for 5 years, with the latest figure at $288154.0 in Q1 2026.

  • On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $288154.0 in Q1 2026; TTM through Mar 2026 was $288154.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1.8 million, changed N/A from the prior year.
  • Net Shares Issued and Repurchased was $288154.0 for Q1 2026 at Genelux, down from $1.8 million in the prior quarter.
  • The five-year high for Net Shares Issued and Repurchased was $1.8 million in Q4 2025, with the low at $51581.0 in Q1 2024.
  • Average Net Shares Issued and Repurchased over 5 years is $700595.7, with a median of $473896.0 recorded in 2023.
  • The largest YoY upside for Net Shares Issued and Repurchased was 364.39% in 2023 against a maximum downside of 364.39% in 2023.
  • Over 5 years, Net Shares Issued and Repurchased stood at $247785.0 in 2022, then jumped by 364.39% to $1.2 million in 2023, then slumped by 95.52% to $51581.0 in 2024, then jumped by 3400.76% to $1.8 million in 2025, then sank by 84.04% to $288154.0 in 2026.
  • The last three Net Shares Issued and Repurchased figures came in at $288154.0 (Q1 2026), $1.8 million (Q4 2025), and $51581.0 (Q1 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Genelux 108.17 Mn 108.17 Mn - 288,154.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 288,154.00
Dec 31, 2025 1.81 Mn
Mar 31, 2024 51,581.00
Dec 31, 2023 1.15 Mn
Sep 30, 2023 659,638.00
Dec 31, 2022 247,785.00